CRISPR Therapeutics and Casebia Therapeutics Announce … – Nasdaq
Nasdaq |
CRISPR Therapeutics and Casebia Therapeutics Announce …
Nasdaq BASEL, Switzerland and CAMBRIDGE, Mass. and DURHAM, N.C., April 17, 2017– CRISPR Therapeutics, a biopharmaceutical company focused on creating. |
